Skip to article content

The mission of the Harvey L. Neiman Health Policy Institute® is to establish foundational evidence for health policy and radiology practice that promotes the effective and efficient use of health care resources and improves patient care.

August 20, 2026

Summer 2026 Neiman News

New research shaping radiology’s future is here. The Summer Neiman News features new findings on AI, healthcare access, workforce trends, and imaging innovation:
A study found AI matched radiologist interpretations in 97.8% of pulmonary embolism cases, Stroke AI adoption is concentrated in larger, specialized hospitals, Rural patients traveled 135 additional miles for advanced neuroendocrine tumor imaging.

New research shaping radiology’s future is here ☀️

The Summer Neiman News features new findings on AI, healthcare access, workforce trends, and imaging innovation:

🤖 A study of 32,000+ CT exams found AI matched radiologist interpretations in 97.8% of pulmonary embolism cases, demonstrating the value of AI-assisted care.

🏥 Stroke AI adoption is concentrated in larger, specialized hospitals, highlighting persistent gaps in access to emerging technologies.

🌎 Rural patients traveled 135 additional miles for advanced neuroendocrine tumor imaging, underscoring how geography can influence access to cancer care.

🔎 Expert Spotlight: Luke Wilkins, MD, highlights new research showing interventional radiology work is increasingly concentrated among dedicated IR physicians, reflecting the specialty’s evolution over the past two decades.

🎓 Meet our newest grant recipient studying equitable cancer care and healthcare economics.

🎉 Congratulations to Kritika Subramanian, MD, MS, of Montefiore Medical Center, recipient of the 2026 Harvey L. Neiman Grant — selected from our largest applicant pool to date.

Her project, “Evaluating the Cost-Effectiveness and Impact on Quality of Life of Radioligand Therapy for Metastatic Castration-Resistant Prostate Cancer,” will examine the economic and policy implications of radioligand therapy for metastatic castration-resistant prostate cancer, with a focus on barriers to adherence for underserved populations. The goal: a policy tool to guide reimbursement decisions and promote more equitable cancer care.

This work builds on Dr. Subramanian’s prior research, “Complex Implementation Factors Demonstrated When Evaluating Cost-Effectiveness and Monitoring Racial Disparities Associated with [18F]DCFPyL PET/CT in Prostate Cancer Men” (Scientific Reports, 2023 doi: 10.1038/s41598-023-35567-w.), conducted with co-investigator Joseph R. Osborne, MD, PhD, FACR, of Well Cornell Medicine.

Congratulations to Dr. Subramanian and her team — we look forward to the impact this research will have on radiology policy!

Data that matters for radiology’s future.

Read the full newsletter ▶️

Released: August 19, 2026